Posted On: Thursday, November 6th, 2014
The Centre for Communicable Diseases and Infection Control of the Public Health Agency of Canada, commissioned the “2012 HIV/AIDS Attitudinal Tracking Survey”. The final report (2012 Report) is currently available on the Library and Archives website. The report describes findings of the third cycle of a public opinion research study (previous cycles in 2003 and… Read more »
Posted On: Thursday, November 6th, 2014
New and Noteworthy Interactions with transplant drugs added to simeprevir product monograph The U.S. Food and Drug Administration (FDA) recently approved revisions to the product label information for the direct-acting anti-viral medication simeprevir, known by the brand name Galexos in Canada. The revisions highlighted drug interactions with cyclosporine and tacrolimus, which are used to prevent… Read more »
Posted On: Thursday, October 30th, 2014
It has already been a week since we closed our 2014 Fall Conference. Thank you to everyone who attended and made this event a success. We are busy posting all the resources and presentations to our website for all of you who were there and those of you who weren’t. Please remember to check back… Read more »
Posted On: Thursday, October 30th, 2014
The Public Health Agency of Canada is pleased to present the 2011 edition of the Report on Sexually Transmitted Infections in Canada. This report was made possible through the collaboration of all provinces and territories, whose continuous contribution to STBBI surveillance is appreciated and gratefully acknowledged. The Executive Summary will be posted online and a… Read more »
Posted On: Thursday, October 30th, 2014
by Dr. Jason Wong, Clinical Prevention Services, BCCDC Background Provincial sexually transmitted infection (STI) data was used to describe the number of new STI (i.e., chlamydia, gonorrhea and infectious syphilis) case reports in BC overall (1991-2013) and to describe trends for the past ten years (2004-2013) by regional health authority, gender and age. Findings… Read more »
Posted On: Thursday, October 30th, 2014
The Public Health Agency of Canada is pleased to announce a call for membership applications for the Ministerial Advisory Council on the Federal Initiative to Address HIV/AIDS in Canada (MAC-FI) to fill vacant positions. MAC-FI is a council that provides unbiased, non-partisan, evidence-informed, targeted and strategic advice to the Minister of Health. It is comprised… Read more »
Posted On: Saturday, October 11th, 2014
By James Gallagher Health editor, BBC News website The origin of the Aids pandemic has been traced to the 1920s in the city of Kinshasa, in what is now the Democratic Republic of Congo, scientists say. An international team of scientists say a “perfect storm” of population growth, sex and railways allowed HIV to spread…. Read more »
Posted On: Saturday, October 11th, 2014
Posted On: Saturday, October 11th, 2014
New and Noteworthy CATIE-News: A hepatitis C outbreak among HIV-negative gay men in London, England Some HIV-negative gay men may be at risk for getting hepatitis C. Researchers from London, England found 44 cases of acute Hep C infection in HIV-negative gay men between 2010 and 2014. Among HIV-positive gay men, hepatitis C has been… Read more »
Posted On: Saturday, October 11th, 2014
On behalf of the Public Health Agency of Canada’s Centre for Communicable Diseases and Infection Control, I am pleased to announce the release of HIV/AIDS Epi Update – Chapter 1: National HIV Prevalence and Incidence Estimates for 2011. This publication provides more details on methodology, and includes, for the first time, provincial estimates for HIV… Read more »
Posted On: Friday, October 3rd, 2014
In September 2014, Janssen Inc. began marketing a new medicine called Prezcobix in Canada. This medicine contains the following two drugs: darunavir 800 mg (also called Prezista) – an HIV protease inhibitor cobicistat 150 mg – a boosting agent Summary Prezcobix is meant to be used as part of a regimen… Read more »
Posted On: Friday, October 3rd, 2014
On April 1, 2017, the Public Health Agency of Canada’s HIV and Hepatitis C Grants and Contributions funding programs will be integrated into a new funding program called the Community Action Fund. Over the past several months, the Agency has been exploring how best to deliver these funds to support a comprehensive community-based response to… Read more »
